biostudies-literatureYan LDNCATS NIH HHSNIAID NIH HHSFIC NIH HHSNHLBI NIH HHS925464https://www.ebi.ac.uk/biostudies/studies/S-EPMC9937442biostudies-literatureUnknown2<h4>Background</h4>Multidrug therapy is a World Health Organization "best buy" for the prevention and control of noncommunicable diseases. CVD polypills, including ≥2 blood pressure medications, and a statin with or without aspirin, are an effective, scalable strategy to close the treatment gap that exists in many low- and middle-income countries, including Haiti. We estimated the number of Haitian adults eligible for an atherosclerotic CVD (ASCVD) polypill, and the number of potentially preventable CVD events if polypills were implemented nationally.<h4>Methods</h4>We used cross-sectional data from the Haiti CVD Cohort, a population-based cohort of 3,005 adults ≥18 years in Port-au-Prince, to compare two polypill implementation strategies: high-risk primary prevention and secondary prevenFrontiers in epidemiologyPolypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country.PMC9937442D43 TW011972UL1 TR002384K24 HL163393R01 HL143788UM1 AI069421Huffman MDMetz MSt Preux SRouzier VApollon AMcNairy MLDade EMorisset BSabwa SPape JWPierre JLYan LDSufra RDeschamps MfalsePolypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country.<h4>Background</h4>Multidrug therapy is a World Health Organization "best buy" for the prevention and control of noncommunicable diseases. CVD polypills, including ≥2 blood pressure medications, and a statin with or without aspirin, are an effective, scalable strategy to close the treatment gap that exists in many low- and middle-income countries, including Haiti. We estimated the number of Haitian adults eligible for an atherosclerotic CVD (ASCVD) polypill, and the number of potentially preventable CVD events if polypills were implemented nationally.<h4>Methods</h4>We used cross-sectional data from the Haiti CVD Cohort, a population-based cohort of 3,005 adults ≥18 years in Port-au-Prince, to compare two polypill implementation strategies: high-risk primary prevention and secondary preven2022-01-01T00:00:00Z20222026-07-15T13:58:23.05Z2026-07-06T03:08:35.547ZS-EPMC99374423681634110.3389/fepid.2022.925464